Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
Some patients with diabetes may be missing critical safety alerts on their phones, the FDA warned on Wednesday.
Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.
Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...
The Food and Drug Administration is warning that critical alerts from diabetes devices may fail to reach users, risking ...